246 related articles for article (PubMed ID: 16514058)
1. Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin.
Shariat-Madar Z; Mahdi F; Warnock M; Homeister JW; Srikanth S; Krijanovski Y; Murphey LJ; Jaffa AA; Schmaier AH
Blood; 2006 Jul; 108(1):192-9. PubMed ID: 16514058
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.
Fang C; Stavrou E; Schmaier AA; Grobe N; Morris M; Chen A; Nieman MT; Adams GN; LaRusch G; Zhou Y; Bilodeau ML; Mahdi F; Warnock M; Schmaier AH
Blood; 2013 Apr; 121(15):3023-32. PubMed ID: 23386129
[TBL] [Abstract][Full Text] [Related]
3. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
Fang C; Schmaier AH
Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
[TBL] [Abstract][Full Text] [Related]
4. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
5. Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor.
Stavrou EX; Fang C; Merkulova A; Alhalabi O; Grobe N; Antoniak S; Mackman N; Schmaier AH
Blood; 2015 Jan; 125(4):710-9. PubMed ID: 25339356
[TBL] [Abstract][Full Text] [Related]
6. Global chimeric exchanges within the intracellular face of the bradykinin B2 receptor with corresponding angiotensin II type Ia receptor regions: generation of fully functional hybrids showing characteristic signaling of the AT1a receptor.
Yu J; Prado GN; Taylor L; Piserchio A; Gupta A; Mierke DF; Polgar P
J Cell Biochem; 2002; 85(4):809-19. PubMed ID: 11968020
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
De Gennaro Colonna V; Fioretti S; Rigamonti A; Bonomo S; Manfredi B; Muller EE; Berti F; Rossoni G
J Hypertens; 2006 Jan; 24(1):95-102. PubMed ID: 16331106
[TBL] [Abstract][Full Text] [Related]
9. K317, R319, and E320 within the proximal C-terminus of the bradykinin B2 receptor form a motif important for phospholipase C and phospholipase A2 but not connective tissue growth factor related signaling.
Yu J; Liu B; Eramian D; Mierke D; Taylor L; Polgar P
J Cell Biochem; 2004 Jun; 92(3):547-59. PubMed ID: 15156566
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of angiotensin-converting enzyme inhibitor induced thrombolysis in Wistar rats.
Gryglewski RJ; Swies J; Uracz W; Chłopicki S; Marcinkiewicz E
Thromb Res; 2003 Jun; 110(5-6):323-9. PubMed ID: 14592556
[TBL] [Abstract][Full Text] [Related]
11. Physiologic activities of the contact activation system.
Schmaier AH
Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin/B
Lara LS; Bourgeois CR; El-Dahr SS; Prieto MC
Physiol Rep; 2017 Apr; 5(7):. PubMed ID: 28373410
[TBL] [Abstract][Full Text] [Related]
13. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH; Busse R
Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
[TBL] [Abstract][Full Text] [Related]
14. Coulombic and hydrophobic interactions in the first intracellular loop are vital for bradykinin B2 receptor ligand binding and consequent signal transduction.
Yu J; Polgar P; Lubinsky D; Gupta M; Wang L; Mierke D; Taylor L
Biochemistry; 2005 Apr; 44(14):5295-306. PubMed ID: 15807523
[TBL] [Abstract][Full Text] [Related]
15. Hybrid formation between the intracellular faces of the bradykinin B2 and angiotensin II AT1 receptors and signal transduction.
Yu J; Prado GN; Taylor L; Pal-Ghosh R; Polgar P
Int Immunopharmacol; 2002 Dec; 2(13-14):1807-22. PubMed ID: 12489795
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin enhances in vitro procoagulant and antifibrinolytic properties of rat vascular endothelial cells.
Kimura S; Tsuji H; Nishimura H; Kato H; Ukimura N; Yano S; Kunieda Y; Kawano H; Nakagawa K; Nakagawa M
Thromb Res; 2002 Apr; 106(1):41-50. PubMed ID: 12165288
[TBL] [Abstract][Full Text] [Related]
17. Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor.
Baydoun AR; Woodward B
Br J Pharmacol; 1991 Jul; 103(3):1829-33. PubMed ID: 1657268
[TBL] [Abstract][Full Text] [Related]
18. Chimeric exchanges within the bradykinin B2 receptor intracellular face with the prostaglandin EP2 receptor as the donor: importance of the second intracellular loop for cAMP synthesis.
Pal-Ghosh R; Yu J; Prado GN; Taylor L; Mierke DF; Polgar P
Arch Biochem Biophys; 2003 Jul; 415(1):54-62. PubMed ID: 12801512
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin as a major endogenous regulator of endothelial function.
Gryglewski RJ; Uracz W; Chłopicki S; Marcinkiewicz E
Pediatr Pathol Mol Med; 2002; 21(3):279-90. PubMed ID: 12056503
[TBL] [Abstract][Full Text] [Related]
20. A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin-Angiotensin Systems.
Schmaier AH
Front Med (Lausanne); 2016; 3():61. PubMed ID: 27965959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
